CHANDLER, Ariz.–(BUSINESS WIRE)–In 1997, Arizona Governor Jan D. Hull established a statewide focus on the state’s bioscience cluster. Now, twenty years later, Arizonans and visitors from across the United States are coming together to exchange ideas, celebrate success and gain a glimpse of even greater opportunities for innovation in the future.
Over this 20-year span, Arizona has gained a reputation as the state with the “collaborative gene” and attracts thought leaders looking to discover, develop, and deliver life-changing and life-saving innovations to patients.
By conservative estimates, over $18 billion has been invested in the bioscience and healthcare sector by public and private sources over the last two decades. The results include new business starts, business expansions, IPOs, and multi-billion dollar acquisitions by global companies who chose to stay and grow in the state. The most recent numbers (TEConomy 2016) show that Arizona is now home to over 1,400 life science firms. New or expanded research facilities house teams that are working on solutions to address some of the world’s greatest health challenges including Alzheimer’s and other neurodegenerative diseases, cancer, and heart disease. Arizona’s network of world-class hospitals grew as local systems expanded and new organizations entered the market. Today, Arizona is home to top-tier research facilities, world-class centers for patient care, and universities that lead in research while training the bioscience leaders of tomorrow.